Update on Juvenile Systemic Sclerosis

被引:17
作者
Foeldvari, Ivan [1 ]
机构
[1] Schon Klin Hamburg Eilbek, Ctr Treatment Scleroderma & Uveitis Childhood & A, Hamburg Ctr Pediat & Adolescent Rheumatol, Teaching Unit,Semmelweis Med Sch, D-22081 Hamburg, Germany
关键词
Juvenile systemic sclerosis; !text type='jS']jS[!/text]Sc; Juvenile scleroderma; Pediatric rheumatology; Orphan pediatric diseases; PULMONARY ARTERIAL-HYPERTENSION; CLINICAL-TRIALS; CLASSIFICATION CRITERIA; AMERICAN-COLLEGE; OUTCOME MEASURES; DISEASE-ACTIVITY; SCLERODERMA; INVOLVEMENT; CHILDHOOD; DIAGNOSIS;
D O I
10.1007/s11926-014-0491-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Juvenile systemic sclerosis is an orphan disease of the macro- and microvasculature with an unknown etiology. Although pediatric and adult classification systems have been developed, neither has been validated yet. Recent publications have shown a shift in the subset pattern in juvenile-onset adult patients, with a better outcome in these patients as compared with young adult patients. As a first step in assessing activity, damage, and severity, a pediatric severity score-a modification of the adult Medsger scale-was proposed but has not been validated. An activity score also has been developed but has not yet been published. Currently, treatment approaches are based only on adult data, and problems exist in extrapolating these data to a pediatric population.
引用
收藏
页数:5
相关论文
共 41 条
[1]  
Bonella P, 2011, SARCOIDOSIS VASC DIF, V28, P27
[2]   Is immunosuppressive therapy the anchor treatment to achieve remission in systemic sclerosis? [J].
Cappelli, Susanna ;
Bellando-Randone, Silvia ;
Guiducci, Serena ;
Matucci-Cerinic, Marco .
RHEUMATOLOGY, 2014, 53 (06) :975-987
[3]   Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development [J].
Castelino, Flavia V. ;
Varga, John .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (11) :1077-1090
[4]  
Daoussis D, 2012, CLIN EXP RHEUMATOL, V30, pS17
[5]   Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study [J].
Elhai, Muriel ;
Meunier, Marine ;
Matucci-Cerinic, Marco ;
Maurer, Britta ;
Riemekasten, Gabriela ;
Leturcq, Tifenn ;
Pellerito, Raffaele ;
Von Muehlen, Carlos Alberto ;
Vacca, Alessandra ;
Airo, Paolo ;
Bartoli, Francesca ;
Fiori, Ginevra ;
Bokarewa, Maria ;
Riccieri, Valeria ;
Becker, Mike ;
Avouac, Jerome ;
Mueller-Ladner, Ulf ;
Distler, Oliver ;
Allanore, Yannick .
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (07) :1217-1220
[6]   Healthy children have a significantly increased skin score assessed with the modified Rodnan skin score [J].
Foeldvari, I ;
Wierk, A .
RHEUMATOLOGY, 2006, 45 (01) :76-78
[7]   Favourable outcome in 135 children with juvenile systemic sclerosis:: results of a multi-national survey [J].
Foeldvari, I ;
Zhavania, M ;
Birdi, N ;
Cuttica, RJ ;
de Oliveira, SHF ;
Dent, PB ;
Elborgh, R ;
Falcini, F ;
Ganser, G ;
Girschick, H ;
Häfner, R ;
Joos, R ;
Kuis, W ;
Pelkonen, P ;
Prieur, AM ;
Rostropowicz-Denisiewicz, K ;
Russo, R ;
Savolainen, A ;
Siamopoulou-Mayridou, A ;
Zulian, F .
RHEUMATOLOGY, 2000, 39 (05) :556-559
[8]   Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: data from the EUSTAR database [J].
Foeldvari, Ivan ;
Tyndall, Alan ;
Zulian, Francesco ;
Mueller-Ladner, Ulf ;
Czirjak, Laszlo ;
Denton, Chris ;
Kowal-Bielecka, Ottilia ;
Bancel, Dominique Farge ;
Matucci-Cerinic, Marco .
RHEUMATOLOGY, 2012, 51 (10) :1832-1837
[9]   Characteristics of Patients with Juvenile Onset Systemic Sclerosis in an Adult Single-center Cohort [J].
Foeldvari, Ivan ;
Nihtyanova, Svetlana I. ;
Wierk, Angela ;
Denton, Christopher P. .
JOURNAL OF RHEUMATOLOGY, 2010, 37 (11) :2422-2426
[10]   Incidence of Childhood Linear Scleroderma and Systemic Sclerosis in the UK and Ireland [J].
Herrick, Ariane L. ;
Ennis, Holly ;
Bhushan, Monica ;
Silman, Alan J. ;
Baildam, Eileen M. .
ARTHRITIS CARE & RESEARCH, 2010, 62 (02) :213-218